Skip to main content

Autologous BMT for Treatment of Experimental Autoimmune Diseases

  • Chapter
Molecular Biology of Hematopoiesis 5

Abstract

For many experimental autoimmune diseases (AID) the predisposition to the disease was shown to reside in the bone marrow (BM) as recently reviewed by Van Bekkum (1) and Marmont (2). Like in individual humans, genetically different inbred rodent strains vary in their susceptibility to experimentally induced AID. The permanent engraftment of BM from susceptible animals in lethally irradiated resistant animals rendered the recipients suscepti¬ble, and vice versa. The finding that the transplantation of purified hemopoietic stem cells from spontanously autoimmune-prone NZB and (NZW x BXSB) F1 mice into normal mice led to the development of AID in the recipients, suggested that genetic defects residing in the hemopoietic stem cell determine the development of AID in the case of the hereditary forms (3,4). Factors like sex and environment (5,6,7) appear to act only as modulating factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Van Bekkum DW. BMT in experimental autoimmune diseases (review) Bone Marrow Transplant. 1993, 11: 183 – 187

    PubMed  Google Scholar 

  2. Marmont AM. Immune ablation followed by stem cell rescue: a new radical approach to the treatment of severe autoimmune diseases. Forum Trends Exp. Clin. Med. 1995, 5: 4 – 15.

    Google Scholar 

  3. Sardina EE, Sugiura K, Ikehara S, Good RA. Transplantation of wheat germ agglutinin-positive he¬matopoietic cells to prevent or induce systemic autoimmune disease. Proc. Natl.Acad. Sci. USA 1991, 83: 3218 – 3222.

    Article  Google Scholar 

  4. Ikehara S, Kawamura M, Takao F et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc.Natl.Acad.Sci. USA 1990, 87: 8341 – 8344.

    Article  PubMed  CAS  Google Scholar 

  5. Leiter EH. The role of environmental factors in modulating insulin dependant diabetes. The role of micro-organisms in non-infectious disease. 39 – 55, 1990.

    Google Scholar 

  6. Steinberg AD, Raveché ES, Laskin CA et al. Systemic lupus erythematosus: insights from animal models. Ann Intern. Med. 1984, 100: 714 – 727.

    PubMed  CAS  Google Scholar 

  7. Denman AM. Sex hormones, autoimmune diseases and immune responses. Br. Med. J. 1991, 303: 2 – 3.

    Article  CAS  Google Scholar 

  8. Van Bekkum DW, Bohre EPM, Houben PFJ, Knaan S. Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc.Natl.Acad.Sci. USA 1989, 86: 10090 – 10094.

    Article  PubMed  Google Scholar 

  9. Ikehara S, Good RA, Nakamura T et al. Rationale for bone marrow tranplantation in the treatment of autoimmune diseases. Proc. Natl. Acad. Sci. USA 1985, 82: 2483 – 2487.

    Article  PubMed  CAS  Google Scholar 

  10. Ikehara S, Yasumizu R, Inaba M et al.Longterm observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc. Natl. Acad. Sci. USA 1989, 86: 3306 – 3310.

    Article  PubMed  CAS  Google Scholar 

  11. Kamiya M, Sohen S, Yamane T, Tanaka S. Effective treatment of mice with type II collagen induced arthritis with lethal irradiation and bone marrow tranplantation. J. Rheumatol. 1993, 20: 225 – 230.

    PubMed  CAS  Google Scholar 

  12. Baldwin JL, Storb R, Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum. 1977, 20: 1043 – 1048.

    Article  PubMed  CAS  Google Scholar 

  13. Jacobs P. Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow tranplantation for drug-induced aplastic anaemia. Bone marrow transpl. 1986, 1: 237 – 239.

    CAS  Google Scholar 

  14. Lowenthal RM, Cohen ML, Atkinson K, Biggs J. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J. Rheumatol. 1993, 20: 137 – 140.

    PubMed  CAS  Google Scholar 

  15. Eedy DJ, Burrows D, Bridges JM, Jones FGC. Clearance of severe psoriasis after allogeneic bone marrow tranplantation. Br. Med. J. 1990, 300: 908.

    Article  CAS  Google Scholar 

  16. Liu Yin JA, Jowill SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukemia. Bone marrow transplant. 1992, 9: 31 – 33.

    Google Scholar 

  17. Knaan-Shanzer S, Houben P, Kinweí-Bohré EPM, Van Bekkum DW. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone marrow transpl. 1991, 8: 33 – 338.

    Google Scholar 

  18. Pestronk A, Drachman DB, Teoh R, Adams RN. Combined short-term immunotherapy for experimental autoimmune myasthenia gravis. Ann Neurol. 1983, 14: 235 – 241.

    Article  PubMed  CAS  Google Scholar 

  19. Salzman D, Tami J, Jackson C etal. Clinical remission of myasthenia gravis (MG) in a patient (PT) after high dose therapy and autologous transplantation with CD34+ stem cells. Blood 1994, 84 suppl.l 206a.

    Google Scholar 

  20. Tourtelotte WW, Potvin AR, Baumhefner RW et al. Multiple sclerosis de novo CNS IgG synthesis: effect of CNS irradiation. Arch. Neurol. 1980, 37: 620 – 624.

    Google Scholar 

  21. Van Gelder M, Kinwel-Bohré EPM, Van Bekkum DW. Treatment of experimental allergic encephalomye¬litis in rats with total body irradiation and syngeneic BMT. Bone marrow transpl. 1993, 11: 233 – 241.

    Google Scholar 

  22. Van Gelder M. Treatment of relapsing experimental autoimmune encephalomyelitis with partially MHC-matched allogeneic bone marrow transplantation. Thesis Leiden 1995.

    Google Scholar 

  23. Van Gelder M, Van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. In press Bone Marrow Transpl. 1995

    Google Scholar 

  24. Karussis DM, Slavin S, Ben-Nun A. Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation. J. Neuroimmunol. 1992, 39: 201 – 210.

    Article  PubMed  CAS  Google Scholar 

  25. Van Gelder M, Mulder M, Van Bekkum DW. The feasibility of pseudoautologous bone marrow transplantation for treatment of relapsing experimental autoimmune encephalomyelitis in rats, submitted.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Plenum Press, New York

About this chapter

Cite this chapter

van Bekkum, D.W., van Gelder, M. (1996). Autologous BMT for Treatment of Experimental Autoimmune Diseases. In: Abraham, N.G., Asano, S., Brittinger, G., Maestroni, G.J.M., Shadduck, R.K. (eds) Molecular Biology of Hematopoiesis 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0391-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0391-6_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-8031-3

  • Online ISBN: 978-1-4613-0391-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics